September 14, 2021 – Medtronic plc (Dublin, Ireland) announced a pilot program with Mpirik to address disparities in care associated with the prevention of sudden cardiac arrest (SCA).
The Medtronic collaboration with Mpirik also involves Vizient, Inc. (Irving, TX). This pilot program aims to identify patients at higher risk for SCA, and identify them earlier in their care journey.
Mpirik’s artificial intelligence platform, Cardiac Intelligence®, will screen electronic health record (EHR) data at five pilot hospitals, including three Vizient member hospitals, to spot patients, regardless of race or gender, who meet prespecified clinical criteria for being at risk of SCA.
Mpirik will provide an automated alert through the EHR system for these patients, enabling clinicians to determine appropriate follow-up care. The identification process will continue to protect patient health information, none of which will be shared with Medtronic or Vizient.